BRUKINSA DIN 02512963
Status: Marketed
Holder: BEONE MEDICINES I GMBH
Available to quote
Health Canada record
| Active ingredient(s) | ZANUBRUTINIB 80 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01EL03 ZANUBRUTINIB |
|---|
| Original market date | 30-Mar-2021 |
|---|
| Current status date | 24-Nov-2025 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZANUBRUTINIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02554267 | BRUKINSA | BEONE MEDICINES I GMBH | Tablet | ZANUBRUTINIB 160 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36424 | 2025-11-24 | New Drug Submission (NDS) | Administrative: Change in manufacturer name |
| 25315 | 2021-03-01 | New Drug Submission (NDS) | |
International API supply for ZANUBRUTINIB
3 active FDA Drug Master Files.
Request a quote for BRUKINSA
How to read a Canadian DIN record